Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic is FDA-approved exclusively for type 2 diabetes management, not weight loss. However, the active ingredient semaglutide has become the cornerstone of personalized weight loss therapy when prescribed by licensed providers through compounded formulations. PlexusDx connects patients with this evidence-based option through licensed 503A compounding pharmacies, starting at just $149 per month.
Why Ozempic Isn't Labeled for Weight Loss
The FDA approved Ozempic (semaglutide injection) in 2017 specifically for improving blood sugar control in adults with type 2 diabetes. Its weight loss benefit emerged as a secondary observation during clinical trials, where patients experienced significant appetite suppression and reduced caloric intake. Because the original indication was diabetes, not obesity, the brand-name Ozempic carries no weight loss label.
Novo Nordisk developed a separate product called Wegovy with the identical semaglutide molecule, dosed specifically for weight loss and FDA-approved in 2021. However, Wegovy's cost ($969–$1,550 per month for brand-name) and supply constraints have driven many patients toward compounded alternatives. PlexusDx sources semaglutide from licensed 503A compounding pharmacies, delivering the same active compound at significantly lower cost without requiring insurance.
How Semaglutide Works for Weight Loss
Semaglutide is a GLP-1 receptor agonist—a synthetic hormone that mimics glucagon-like peptide-1, which regulates appetite and blood sugar naturally. When injected, it slows gastric emptying, making meals feel more satisfying longer, and signals the brain's satiety centers that you've eaten enough. Clinical trials show patients on semaglutide consume 500–800 fewer calories daily without intentional restriction.
The weight loss effect isn't instantaneous. Most patients experience gradual appetite reduction over 4–8 weeks, with maximum benefit achieved at higher doses over 16–20 weeks of titration. PlexusDx's approach personalizes this journey: your dose may need to go up over time to maintain effectiveness, but your price remains flat at $149 per month.
Off-Label Prescribing and Legal Considerations
Once an FDA-approved medication exists, prescribers can legally use it for conditions beyond its original label—a practice called off-label prescribing. Semaglutide for weight loss represents standard off-label practice supported by robust clinical evidence and adopted by major medical societies. Your provider assumes responsibility for ensuring the off-label use is medically appropriate for your specific health profile.
The distinction matters: compounded semaglutide is not FDA-approved as a weight loss drug, but it contains an FDA-approved active ingredient manufactured under strict quality standards. PlexusDx partners exclusively with licensed 503A compounding pharmacies, which operate under pharmaceutical compounding regulations and are subject to state board oversight. This ensures medication safety equivalent to brand-name products at a fraction of the cost.
PlexusDx Semaglutide: Cost, Access, and Genetic Personalization
PlexusDx Compounded Semaglutide Injection starts at $149 per month—a 70–85% reduction versus brand-name Wegovy. No insurance is required, no membership fees apply, and the medication is HSA/FSA eligible. PlexusDx serves all 50 states and handles the entire process: online consultation, prescription coordination, and direct pharmacy shipping to your door.
For patients seeking deeper insight into their metabolic response, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month). This test examines 14 metabolic pathways and 49 peptides, including key variants in the GLP1R gene (rs6923761), which influences how effectively your body responds to semaglutide. This personalization helps your provider optimize dosing and medication selection before committing to long-term therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it legal for my doctor to prescribe Ozempic or semaglutide for weight loss?
Yes. Once FDA-approved, medications can be prescribed off-label for other conditions based on clinical evidence. Semaglutide for weight loss is standard off-label practice supported by major medical organizations. Your provider must determine it's medically appropriate for you.
What's the difference between Ozempic, Wegovy, and compounded semaglutide?
All three contain identical semaglutide molecules. Ozempic is labeled for diabetes, Wegovy for weight loss, and compounded semaglutide is the same active ingredient manufactured by licensed pharmacies. The clinical effect is equivalent, but compounded options cost significantly less.
How quickly will I lose weight on semaglutide?
Weight loss typically becomes noticeable after 4–8 weeks as appetite suppression increases. Most significant results occur over 16–20 weeks of dose escalation. Clinical trials show average weight loss of 15–22% of body weight over one year at therapeutic doses.
How much does PlexusDx semaglutide cost compared to brand names?
PlexusDx Compounded Semaglutide Injection starts at $149 per month—versus $969–$1,550 monthly for Wegovy. Your dose may increase over time, but your price stays flat. No insurance, membership fees, or hidden costs apply.
What is the Precision Peptide Genetic Test and should I get it?
This $99 test examines 14 metabolic pathways and 150+ genetic insights, including your GLP1R variant, which predicts how well you'll respond to semaglutide. It's optional but helps your provider personalize your medication and dosing strategy from the start.
Is compounded semaglutide as safe as brand-name Wegovy?
PlexusDx sources semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict pharmaceutical regulations and state board oversight. The active ingredient and manufacturing standards are equivalent to brand-name products.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Tirzepatide Need to Be Refrigerated? Essential Storage Guidelines for Your Medication
Online Semaglutide Prescription: How to Get Started Safely with TrimRX